← Open Payments lookup

ADELINE MANGWA: Open Payments

NPI 1497015283 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,153 in 99 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $899 · 2025 $3,153

Food & beverage: $2,362Travel & lodging: $792
CompanyPaymentsAmount
Neuronetics, Inc.5$987
ABBVIE INC.16$436
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$393
Janssen Pharmaceuticals, Inc8$308
Otsuka America Pharmaceutical, Inc.6$211
Vanda Pharmaceuticals Inc.9$192
Lundbeck LLC8$168
Alkermes, Inc.12$151
Teva Pharmaceuticals USA, Inc.6$134
Takeda Pharmaceuticals U.S.A., Inc.3$63

Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, ARISTADA, INVEGA SUSTENNA, UZEDY.

Industry payments across MD — which companies pay providers there.